Investors

Verndari is currently supported by a select group of two dozen “Angel Investors”.

Many Investors have held Senior Executive Positions in the Pharmaceutical Industry, Healthcare Industry and Banking.

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. Steve F. Dowdy
Professor, Cellular and Molecular Medicine, University of California, San Diego, School of Medicine

Dr. Dowdy research interests include mechanisms of G1 cell cycle progression, macromolecular drug delivery using TAT Peptide Transduction Domains, mRNA replicons, RNAi and a class of RNAi pro drugs known as RiboNucleic Neutrals (RNN).

read more